На
ук
а о жизни и з
доровье №2, 2020
109
in bipolar disorder than in psychotic disorders: A multicenter-observational study // Hum.
Psychopharmacol. John Wiley and Sons Ltd, 2017. Vol. 32, № 3.
13. Martinotti G. et al. Novel Psychoactive Substances in Young Adults with and without
Psychiatric Comorbidities // Biomed Res. Int. Hindawi Limited, 2014. Vol. 2014.
14. Vallersnes O.M. et al. Psychosis associated with acute recreational drug toxicity: A
European case series // BMC Psychiatry. BioMed Central Ltd., 2016. Vol. 16, № 1.
15. Oluwabusi O.O. et al. Synthetic Cannabinoid-Induced Psychosis: Two Adolescent
Cases // J. Child Adolesc. Psychopharmacol. Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd
Floor New Rochelle, NY 10801 USA , 2012. Vol. 22, № 5. P. 393–395.
16. Schifano F. et al. NPS: Medical consequences associated with their intake // Current
Topics in Behavioral Neurosciences. Springer Verlag, 2017. Vol. 32. P. 351–380.
Прилуцкая М.В.
https://orcid.org/0000-0002-9099-316X; SPIN 7582-3916
Керимбаева А.Р.
https://orcid.org/0000-0001-8926-3699
Манарбеков Е.М.
https://orcid.org/0000-0002-3662-3977
Достарыңызбен бөлісу: | 
